Effect of Seminal Plasma Insemination on Pregnancy Rates After IVF-ET

Effect on Implantation and Pregnancy Rates Clinical Trial

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01809366
• Other study ID #: 65/10
• Status: Completed
• Phase: N/A
• First received: March 10, 2013
• Last updated: March 10, 2013
• Start date: January 2012
• Est. completion date: March 2013

Study information

• Verified date: January 2013
• Source: Assaf-Harofeh Medical Center
• Contact: n/a
• Is FDA regulated: No
• Health authority: Israel: Ministry of Health
• Study type: Interventional

Clinical Trial Summary

Seminal plasma insemination into the vaginal vault of patients undergoing IVF-ET increases uterine receptivity.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 200
• Est. completion date: March 2013
• Est. primary completion date: February 2013
• Accepts healthy volunteers: No
• Gender: Female
• Age group: 20 Years to 41 Years

Eligibility

Inclusion Criteria:

• patients undergoing oocyte pick up for IVF treatment

Exclusion Criteria:

• endometriosis

• low responders

• uterine malformations

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment

Related Conditions & MeSH terms

• Effect on Implantation and Pregnancy Rates

Intervention

Procedure:
• seminal plasma insemination

Locations

Country	Name	City	State
Israel	Infertility and IVF Unit, Assaf harofeh Medical Center	Zrifin

Sponsors (1)

Lead Sponsor	Collaborator
Assaf-Harofeh Medical Center

Country where clinical trial is conducted

Israel, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	implantation rate		4 weeks after ET	No
Secondary	clinical pregnancy rate		4 weeks after ET	No
Secondary	ongoing pregnancy rate		6 weeks after ET	No